In this study, we assessed the expressions of FAP, CD10 and GPR77 in CAFs of gastric cancer samples after and before treatment, and evaluated their predictive values on the efficacy of NCT and prognosis in locally advanced gastric cancer patients. The gene discussed is C5AR2; the disease is gastric cancer.